2 weeks Zacks Industry Outlook Highlights Incyte, BioMarin, Exelixis, Halozyme and Blueprint Medicines Zacks X
2 months Biotech Stock Roundup: SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval & More Zacks X
2 months Incyte Collapses. Why Its $750 Million Escient Acquisition Now Looks Shattered. Investor's Business Daily X
3 months Dumont & Blake Investment Advisors LLC Sells 25,529 Shares of Incyte Co. (NASDAQ:INCY) MarketBeat X